Study Design. A retrospective review of prospectively collected data.
D
espite widespread public health campaigns that encourage smoking cessation, 2013 estimates from the National Institutes of Health indicate that roughly 18% of the adult population in the United States continues to smoke cigarettes. 1 The public health burden is substantial, with an estimated 200,000 deaths annually, and an increased risk of numerous chronic medical conditions. 2 Furthermore, the overall economic burden is estimated to exceed $200 billion annually for chronic conditions in patients who smoke, 3 with notable increases in health care costs for complications associated with smoking after elective surgical procedures. [4] [5] [6] [7] Within general orthopedics, several studies have reported increased rates of pseudoarthrosis, wound complications, and systemic morbidity after surgical procedures in smokers. [8] [9] [10] [11] [12] [13] Preliminary studies in the total joints literature have reported decreased postoperative complications in smokers who participated in a structured smoking cessation program. [8] [9] [10] Thus, smoking cessation before elective procedures has been advocated, [13] [14] [15] and many institutions have implemented programs designed to encourage smoking cessation. However, comparatively few studies have reported on perioperative complications in smokers following spine surgeries, and those results have been inconsistent, with some authors reporting no difference in morbidity rates among active smokers. 11, 16, 17 Furthermore, to the best of our knowledge, no studies in spine have compared complication rates among active smokers against those who have previously quit. Thus, the purpose of the current study was to compare short-term morbidity rates for patients undergoing lumbar spine surgery who were either current smokers, former smokers, or never smokers, while also investigating any dose-dependent relationship between morbidity risk and pack-year history of smoking. The data should be useful in counseling smokers about their morbidity risk, and in helping to risk stratify patients perioperatively.
MATERIALS AND METHODS

Data Source and Collection Methods
This study received Institutional Review Board Approval and was HIPAA compliant. The American College of Surgeons (ACS) collects morbidity data for 30-days postoperatively following surgical cases at more than 500 hospitals around the United States, and these data are prospectively entered into a database titled the National Surgical Quality Improvement Program (NSQIP). A Surgical Clinical Reviewer (SCR) performs the data collection on-site through a combination of chart review and contact with the patients and surgeons for clarification. The datasets are routinely audited, with inter-observer disagreement rates of less than 2%. 18 There is a roughly equal mix of public and private hospitals in the cohort. The dataset has been widely accepted in the orthopedic literature, [19] [20] [21] [22] and a detailed description of the methodology is available from the ACS. 23 We retrospectively queried this database using Current Procedural Terminology (CPT) codes for patients undergoing lumbar spine procedures between January 1, 2012, and December 31, 2013. We included patients over 18 years of age with a CPT code for lumbar discectomy, lumbar laminectomy, posterior lumbar fusion, anterior lumbar fusion, or deformity surgery involving the lumbar spine. Patients with a current wound infection, pre-operative sepsis, an active infection elsewhere on their body, a current pneumonia, a procedure within 30 days postoperatively, patients in a coma, or patients who underwent a nonelective procedure were excluded. Patients with isolated thoracic or cervical spine procedures were also excluded. Lastly, we excluded any patient who did not have a smoking history documented. After exclusions, 35,477 cases were available for analysis. A complete listing of the included CPT codes and exclusion criteria is available in the appendix (Appendix Table 1 , http://links.lww.com/BRS/ B56).
Statistical Analysis
Patients were categorized into cohorts of those who reported never smoking (''never smokers,'' n ¼ 27,426), those who reported having quit smoking more than 12 months ago (''former smokers,'' n ¼ 562), and those who reported ongoing smoking within the last year (''current smokers,'' n ¼ 7669) (Appendix Table 1 , http://links.lww.com/BRS/ B56). In order to identify potential confounders between the 3 groups, we first compared the procedure types performed and patient comorbidities in a univariate analysis using an unbalanced analysis of variance (ANOVA) model for continuous variables and a Chi-square test for categorical variables. This univariate analysis revealed multiple differences between the three patient cohorts (Table 1) . Thus, in an attempt to control for confounders, we then conducted a multivariate logistic regression analysis, the technique for which has been well described in other studies. [24] [25] [26] [27] Patient variables with a P <0.1 in the univariate model and at least 80% data completion were included in the multivariate model. The multivariate model requires complete patient data, and thus patients with a missing data-point are necessarily excluded. Statistical significance in the multivariate model was defined as a P <0.05.
For our multivariate analysis, we considered 4 categories of complications. Each category required a separate multivariate analysis. The category of ''mortality'' included any patient death within 30 days. The category of ''superficial wound infection'' included patients with an infection confined to the skin or subcutaneous tissues. The composite category of ''wound complications'' included any wound dehiscence, superficial, infection, deep infection, or organ space infection. The composite category of ''total complications'' included any mortality or morbidity that occurred within 30 days. Blood transfusions are frequently considered separately from other complications in the literature, 21 ,28 and we did not include blood transfusions in any of the multivariate analyses. A single patient could potentially have suffered multiple complications in a single category, but was counted only once for each statistical model.
Lastly, in order to further stratify the impact of variable amounts of smoking history, we stratified patients by reported pack-year smoking history. Patients were divided into cohorts of those with ''zero'' reported pack-year history (n ¼ 34,319), 1 to 20 pack-year histories (n ¼ 621), 20 to 40 pack-year histories (n ¼ 333), and greater than 40-pack years (n ¼ 204). These cohorts were then analyzed using the same multivariate analysis described above.
We checked the model performance for discrimination using C-statistics and model calibration using HosmerLemeshow (HL) Chi-square statistics. 24 The data analysis was performed using SAS 9.3 (SAS Institute, Cary, NC). The multivariate models fit the data well, with HL goodness-offit P values from 0.09 to 0.93 and discriminated well, with c-values from 0.66 to 0.75 (Appendix Table 2 , http://links. lww.com/BRS/B56).
RESULTS
In the unadjusted univariate comparison, former smokers had the highest morbidity risk with an overall incidence of 18.9%, as compared with 11.3% and 13.2% for current smokers and never smokers, respectively (P < 0.001, Table 2 ). The most common complication was a blood transfusion. Some prior authors have considered blood transfusions separately from overall complications, and thus, we also separately calculated the incidence of other complications. 21 After excluding blood transfusions, there was no significant difference in the overall complication incidence between the 3 groups (P ¼ 0.47).
In the subsequent multivariate analysis, current smokers were at significantly increased risk of any wound complication (OR [odds ratio] 1.27, 95% CI [95% confidence interval] 1.01-1.58), as well as increased risk of any complication (OR 1.14, 95% CI 1.01-1.29) as compared with patients who never smoked. The risk in former smokers also trended higher, but did not reach significance in either category ( Table 3 ). The risk of mortality was not significantly different across any of the 3 groups.
When stratified by pack-year smoking history, patients who had a 1 to 20 pack-year history, as well as patients with more than 40 pack-year histories both had a significantly higher risk of superficial wound infections (OR 2.1, 95% CI 1.14-4.1 and OR 2.7, 95% CI 1-7.5, respectively) ( Table 4 ). The analysis of overall morbidity risk trended higher in patients with more than 40 pack-year histories, but did not reach significance (OR 1.5, 95% CI 0.9-2.5).
Mortality was such a rare event that there were not enough occurrences to allow stratification by pack-year history, and thus mortality risk was not analyzed in this portion of the analysis.
DISCUSSION
Both modifiable and nonmodifiable risk factors can impact patient outcomes after lumbar spine procedures. 21, 25, 27, 29 Smoking is a modifiable risk factor that has been strongly associated with morbidity risk in total joint arthroplasty, as well as in general orthopedics. [8] [9] [10] 12 However, the literature in spine is less clear, with some authors reporting no increased morbidity among active smokers. 11, 16, 17, [30] [31] [32] Furthermore, some authors have advocated for smoking cessation programs before elective procedures. 9 However, these programs are expensive and time-consuming, 8 and no study has investigated the impact of smoking cessation before lumbar spine procedures. Thus, the purpose of this study was to compare morbidity rates among current, former, and never smokers from a large, heterogeneous national database, as well as to determine whether a dose response occurred in patients with higher pack-year smoking histories. Overall, we found that current smokers were at 
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a significantly higher risk of wound complications and overall morbidity. Former smokers trended toward having a higher risk, but this did not reach significance, and there was a trend toward higher superficial wound complication risk with increased pack-year smoking history. Several of the findings merit further discussion. First, after adjusting for confounders, our study found a small but statistically significant increased systemic morbidity risk for current smokers who undergo elective lumbar spine procedures (OR 1.14, 95% CI 1.01-1.29). This is in contrast to several prior studies. Appaduray demonstrated increased morbidity rates associated with active smoking. 8, 12, 14, 15, 31, 33 Our data are supportive of those conclusions and lend support to practitioners when counseling current smokers about their increased morbidity risk perioperatively.
Second, the most significant increase in morbidity for active smokers was seen in their risk for a peri-operative wound complication. Active smoking has been strongly associated with poor wound healing across multiple surgical disciplines. 14, 15 Nicotine induces peripheral vasoconstriction and local tissue hypoxia, 34 which in turn leads to decreased angiogenesis and epithelialization. 35 Furthermore, collagen is the primary determinant of the tensile strength of a surgical wound, and both human and animal models have shown decreased subcutaneous collagen production in smokers. 18, 36 Thus, the pathophysiologic effects of smoking with regard to wound healing have been clearly established. Nonetheless, clinical studies in spine have been mixed, and some authors have reported no difference in wound healing rates between smokers and nonsmokers. 11, 17, [30] [31] [32] The majority of these studies have been small retrospective series, and may have been underpowered. 30 Here, we reviewed 35,477 cases from a prospectively collected database and reported a small but significantly increased risk of overall wound complications (OR 1.27, 95% CI 1.01-1.58), as well as in superficial wound complications (OR 1.37, 95% CI 1.02-1.85) in current smokers. Some authors have advocated for higher levels of wound prophylaxis in at-risk patients, such as intrawound vancomycin powder, pre-operative chlorhexidene skin washes, and the use of occlusive dressings. 37 It may be particularly reasonable to consider current smokers for this higher level of wound prophylaxis, and we feel that smokers should be counseled about their increased wound complication risk perioperatively.
Third, the morbidity risk in former smokers trended higher, but did not reach significance. Smoking cessation rapidly restores tissue local oxygenation and metabolism. 15 Thus, smoking cessation before elective procedures holds a theoretical benefit, particularly with regard to wound healing, and has been widely advocated. 14, 15 Furthermore, a recent meta-analysis consisting primarily of plastic and general surgery patients pooled 479,150 patients, and concluded that smoking cessation reduced the risk of surgical site infections by more than half, as compared with active smokers. 33 However, few studies in orthopedics have shown any benefit to recent smoking cessation. In this study, patients who were former smokers trended toward having a higher risk of wound complications and overall morbidity, but neither category reached significance. Thus, we feel that the data largely support smoking cessation efforts. However, our study included a heterogeneous mix of patients who had quit smoking more than 1 year before their operation. Further prospective studies with better defined time points at which the patients had stopped smoking would be necessary in order to definitively establish the impact of smoking cessation.
Lastly, prior authors have proposed that there is a dose response to nicotine, with higher lifetime exposures resulting in an increased risk. In the current study, increasing pack-year smoking history trended toward higher rates of superficial wound complications, with both patients who had 1 to 20 pack-year histories as well as patients who had more than 40 pack-year histories demonstrating a significantly increased risk (P < 0.05 for each). The magnitude of risk trended higher in the more than 40 pack-years group (OR 2.7 vs. 2.2), but there was no significant difference between the more than 40 and 1 to 20 pack-year groups. The morbidity risk in patients with 20 to 40 pack-year histories did not reach significance, but there was a wide CI for each tested outcome. Thus, the analysis of pack-year history indicates that nicotine exposure is associated with increased morbidity risk, and there was a trend toward a dose response, but the trend did not reach significance. Overall, we feel that these results support those from our primary analysis comparing current and never smokers, and indicate that smoking is particularly detrimental to superficial wound healing.
Our study has several weaknesses. First, patients selfreported their smoking status, which may underestimate the true prevalence of smoking. 38 The presence of smokers in the category of never-smoker would bias toward a null result, and minimize the true magnitude of morbidity risk due to smoking. Thus, the true impact of smoking may be larger than we have reported here. Second, the dataset only classifies patients as former smokers if they had quit smoking more than 1 year before surgery. Some studies have suggested that smoking cessation even 1 to 2 months before surgery may reduce perioperative risk, although the optimal timing is a topic of considerable debate. 9, [39] [40] [41] We feel that these limitations with regard to smoking status are acceptable, as they result in a conservative estimate as to the impact of smoking status throughout our analysis. Third, multiple differences in medical comorbidities, demographics, and procedure type performed were present between the 3 cohorts in our univariate analysis. Thus, in an attempt to control for confounders, we performed a multivariate logistic regression analysis. The primary conclusions of our study are based on this analysis, as we feel it is less likely than the univariate analysis to be confounded by bias. Nonetheless, the multivariate analysis only includes the variables we can measure from the database, and it is possible that unmeasured sources of bias remain that we did not account for. Fourth, the NSQIP database primarily captures systemic morbidity events, and complications specific to spine such as dural tears and pseudarthrosis rates are not recorded. Furthermore, some complications, such as Deep Vein Thrombosis and Pulmonary Embolis, can occur after the 30-day time point examined here. Thus, inclusion of those complications might increase the overall complication rates reported here, and our conclusions are limited to the short-term complications that occur within 30 days peri-operatively. We tried to emphasize the timeframe of these outcomes in both our abstract and our title. The strengths of the study include the large cohort size, the prospective, high-fidelity data collection across multiple categories of systemic morbidity, and the specific investigation of wound complication risk, which was not well studied in prior papers on this topic.
Overall, we found that current smokers had a small but significantly increased risk of wound complications and overall 30-day morbidity after lumbar spine procedures, as compared with never smokers. The trend toward increased complications in former smokers did not reach significance. Patients with a pack-year history of either 1 to 20 or more than 40 years were both associated with significantly increased superficial wound complication risk, and the magnitude of risk trended higher in the more than 40 pack-years group, which may imply a small dose response. Therefore, we feel it is reasonable to encourage smoking cessation pre-operatively in patients undergoing elective procedures and to council active smokers about their increased morbidity risk.
Key Points
Current smokers had a significantly higher risk of wound complications and overall 30-day morbidity following lumbar spine procedures, than never smokers. The risk in former smokers also trended higher, but did not reach significance. Increasing pack-year history was associated with wound complication risk, suggesting a small doserelated effect. The data largely support smoking cessation efforts before elective procedures.
